총 18,286건 중 1,000건 출력
, 9/100 페이지
-
81
-
miR-16-5p, miR-21-5p, and miR-155-5p in circulating vesicles as psoriasis biomarkers
-
Guzmá
n-Martí
n, Carlos A.;
Jimé
nez-Ortega, Rogelio F.;
Ortega-Springall, Marí
a Fernanda;
Peñ
a-Peñ
a, Mario;
Guerrero-Ponce, Ana Elena;
Vega-Memije, Marí
a Elisa;
Amezcua-Guerra, Luis M.;
Sá
nchez-Muñ
oz, Fausto;
Springall, Rashidi;
;
(Scientific reports,
v.15,
2025,
pp.6971)
-
82
-
Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis
-
Kakehi, Saori;
Nakahama, Ken-ichi;
Morita, Ikuo;
;
(Molecular and cellular biochemistry,
v.301,
2007,
pp.209-217)
-
83
-
Operator loading tasks - W. B. Knowles, Human Factors 5, 155 (April 1963)
-
;
;
(Microelectronics and reliability,
v.3,
1964,
pp.76)
-
84
-
MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma
-
Liu Bowen;
Hu Jingchao;
Zhao Han;
Zhao Li;
Beijing Stomatological Hospital;
Beijing Stomatological Hospital;
Beijing Stomatological Hospital;
Chongqing Medical University Stomatology College: Stomatological Hospital of Chongqing Medical University;
(,
v.,
2021,
)
-
85
-
전기적 신호/광신호 변환 양방향 전송기술
-
최춘기;
황건;
실장기술팀;
실장기술팀;
(전자통신동향분석 = Electronics and telecommunications trends,
v.15,
2000,
pp.33-40)
-
86
-
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
-
Park, Bon;
Choi, Myung Eun;
Ryu, Kyung Ju;
Park, Chaehwa;
Choi, Minki;
Yoon, Sang Eun;
Kim, Won Seog;
Kim, Hyeon Ho;
Hong, Jung Yong;
Kim, Seok Jin;
;
(Experimental cell research,
v.442,
2024,
pp.114248)
-
87
-
MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma
-
;
;
(,
v.,
2021,
)
-
88
-
MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1
-
Li, Ning;
Cui, Tao;
Guo, Wenling;
Wang, Dianwei;
Mao, Li;
Obstetrical Department, Binzhou Central Hospital , Binzhou , Shandong 251700 , People’s Republic of China;
Anesthesiology Department, Huimin County Maternal and Child Health Hospital , Binzhou , Shandong , 251700 , People’s Republic of China;
Obstetrical Department, Binzhou Central Hospital , Binzhou , Shandong 251700 , People’s Republic of China;
Obstetrical Department, Binzhou Central Hospital , Binzhou , Shandong 251700 , People’s Republic of China;
Gynecology Department, Binzhou Central Hospital , Binzhou , Shandong 251700 , People’s Republic of China;
(OncoTargets and therapy,
v.12,
2019,
pp.3181-3196)
-
89
-
MicroRNA-155-5p inhibits the invasion and migration of prostate cancer cells by targeting SPOCK1
-
Yao, Lin-Ya;
Ma, Jun;
Zeng, Xue-Ming;
Ou-Yang, Jun;
Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China;
Department of Urology, Kunshan Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, Jiangsu 215300, P.R. China;
Department of Urology, Kunshan Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Kunshan, Jiangsu 215300, P.R. China;
Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China;
(Oncology letters,
v.20,
2020,
pp.353)
-
90
-
miR‐155 increases stemness and decitabine resistance in triple‐negative breast cancer cells by inhibiting TSPAN5
-
Yang, La‐
Wei;
Wu, Xian‐
Jin;
Liang, Yi;
Ye, Guang‐
Qing;
Che, Yu‐
Chuang;
Wu, Xue‐
Zhen;
Zhu, Xiao‐
Jie;
Fan, Huo‐
Liang;
Fan, Xiang‐
Ping;
Xu, Jun‐
Fa;
Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China;
Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China;
Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China;
Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China;
Department of Clinical Laboratory, Huizhou Municipal Central Hospital, Huizhou, China;
Department of Clinical Laboratory, Huizhou Municipal Central Hospital, Huizhou, China;
Department of Clinical Laboratory, Huizhou Municipal Central Hospital, Huizhou, China;
Department of Clinical Laboratory, Huizhou Municipal Central Hospital, Huizhou;
(Molecular carcinogenesis,
v.59,
2020,
pp.447-461)